Josep Llorens Haemonetics Corp (HAE) insider trading activity

Josep Llorens is EVP, Global Manufacturing of HAEMONETICS CORP. Currently has a direct ownership of 30,940 shares of HAE, which is worth approximately $2.6 Million. The most recent transaction as insider was on May 28, 2024, when has been sold 4,510 shares (Common Stock) at a price of $95.73 per share, resulting in proceeds of $431,742. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.9K

67.58% 3M change

67.58% 12M change

Total Value Held $2.6 Million

Josep Llorens Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2024	SELL Payment of exercise price or tax liability	$431,742 $95.73 p/Share	4,510 Reduced 12.72%	30,940 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	-	14,140 Added 28.51%	35,450 Common Stock
May 20 2024	SELL Open market or private sale	$93,843 $95.08 p/Share	987 Reduced 4.43%	21,310 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$30,633 $95.73 p/Share	320 Reduced 1.96%	16,030 Common Stock
May 17 2024	SELL Open market or private sale	$77,942 $94.82 p/Share	822 Reduced 4.79%	16,350 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	6,267 Added 21.94%	22,297 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$24,932 $94.8 p/Share	263 Reduced 1.44%	17,942 Common Stock

May 16 2024	SELL Open market or private sale	$74,027 $96.14 p/Share	770 Reduced 4.29%	17,172 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$24,894 $96.49 p/Share	258 Reduced 1.4%	18,205 Common Stock
Jul 18 2023	SELL Open market or private sale	$443,520 $90.0 p/Share	4,928 Reduced 21.07%	18,463 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	$281,290 $57.08 p/Share	4,928 Added 17.4%	23,391 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$118,592 $83.34 p/Share	1,423 Reduced 7.16%	18,463 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$28,457 $89.21 p/Share	319 Reduced 1.58%	19,886 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	3,084 Added 13.24%	20,205 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$9,962 $88.16 p/Share	113 Reduced 0.66%	17,121 Common Stock
Jan 23 2023	SELL Open market or private sale	$215,190 $90.0 p/Share	2,391 Reduced 12.18%	17,234 Common Stock
Jan 23 2023	BUY Exercise of conversion of derivative security	$135,258 $56.57 p/Share	2,391 Added 10.86%	19,625 Common Stock
Sep 06 2022	SELL Open market or private sale	$7,452 $73.78 p/Share	101 Reduced 0.58%	17,234 Common Stock
May 19 2022	SELL Open market or private sale	$83,804 $59.1 p/Share	1,418 Reduced 7.56%	17,335 Common Stock
May 16 2022	SELL Open market or private sale	$6,003 $56.1 p/Share	107 Reduced 0.74%	14,413 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	4,340 Added 18.79%	18,753 Common Stock
Sep 07 2021	SELL Open market or private sale	$6,461 $64.61 p/Share	100 Reduced 0.68%	14,520 Common Stock
May 19 2021	SELL Open market or private sale	$6,899 $55.19 p/Share	125 Reduced 0.85%	14,620 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	10,605 Added 41.83%	14,745 Common Stock
May 17 2021	SELL Open market or private sale	$6,381 $55.97 p/Share	114 Reduced 2.68%	4,140 Common Stock

Josep Llorens

EVP, Global Manufacturing

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account